These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 12615716

  • 21. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
    Li J, Huang S, Armstrong EA, Fowler JF, Harari PM.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1477-85. PubMed ID: 16029810
    [Abstract] [Full Text] [Related]

  • 22. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.
    Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki EA, Treiberg J, Hayflick JS, Hallahan DE.
    Cancer Res; 2004 Jul 15; 64(14):4893-9. PubMed ID: 15256460
    [Abstract] [Full Text] [Related]

  • 23. Calcium-sensing receptor activation induces nitric oxide production in H-500 Leydig cancer cells.
    Tfelt-Hansen J, Ferreira A, Yano S, Kanuparthi D, Romero JR, Brown EM, Chattopadhyay N.
    Am J Physiol Endocrinol Metab; 2005 Jun 15; 288(6):E1206-13. PubMed ID: 15657090
    [Abstract] [Full Text] [Related]

  • 24. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery.
    Sonveaux P, Dessy C, Brouet A, Jordan BF, Grégoire V, Gallez B, Balligand JL, Feron O.
    FASEB J; 2002 Dec 15; 16(14):1979-81. PubMed ID: 12397083
    [Abstract] [Full Text] [Related]

  • 25. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
    Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW.
    Circulation; 2003 Dec 23; 108(25):3115-21. PubMed ID: 14676142
    [Abstract] [Full Text] [Related]

  • 26. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
    Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, Losordo DW.
    Circulation; 2005 Mar 08; 111(9):1114-20. PubMed ID: 15723985
    [Abstract] [Full Text] [Related]

  • 27. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R.
    Cancer Res; 2006 Mar 01; 66(5):2673-82. PubMed ID: 16510587
    [Abstract] [Full Text] [Related]

  • 28. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.
    Am J Physiol Endocrinol Metab; 2009 Jun 01; 296(6):E1440-9. PubMed ID: 19351806
    [Abstract] [Full Text] [Related]

  • 29. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
    Du W, Takuwa N, Yoshioka K, Okamoto Y, Gonda K, Sugihara K, Fukamizu A, Asano M, Takuwa Y.
    Cancer Res; 2010 Jan 15; 70(2):772-81. PubMed ID: 20068174
    [Abstract] [Full Text] [Related]

  • 30. Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase.
    Zhang YH, Murphy WJ, Russell SW, Morrison DC, Koide N, Yoshida T, Yokochi T.
    Cell Immunol; 2005 Mar 15; 234(1):16-22. PubMed ID: 15936007
    [Abstract] [Full Text] [Related]

  • 31. Tannin 1-alpha-O-galloylpunicalagin induces the calcium-dependent activation of endothelial nitric-oxide synthase via the phosphatidylinositol 3-kinase/Akt pathway in endothelial cells.
    Chen LG, Liu YC, Hsieh CW, Liao BC, Wung BS.
    Mol Nutr Food Res; 2008 Oct 15; 52(10):1162-71. PubMed ID: 18435486
    [Abstract] [Full Text] [Related]

  • 32. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging.
    Bach MH, Sadoun E, Reed MJ.
    Mech Ageing Dev; 2005 Apr 15; 126(4):467-73. PubMed ID: 15722105
    [Abstract] [Full Text] [Related]

  • 33. PECAM-1 interacts with nitric oxide synthase in human endothelial cells: implication for flow-induced nitric oxide synthase activation.
    Dusserre N, L'Heureux N, Bell KS, Stevens HY, Yeh J, Otte LA, Loufrani L, Frangos JA.
    Arterioscler Thromb Vasc Biol; 2004 Oct 15; 24(10):1796-802. PubMed ID: 15284089
    [Abstract] [Full Text] [Related]

  • 34. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 35. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 36. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.
    Ivanciu L, Gerard RD, Tang H, Lupu F, Lupu C.
    Arterioscler Thromb Vasc Biol; 2007 Feb 15; 27(2):310-6. PubMed ID: 17138934
    [Abstract] [Full Text] [Related]

  • 37. Rapid up-regulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation.
    Kang WS, Tamarkin FJ, Wheeler MA, Weiss RM.
    J Pharmacol Exp Ther; 2004 Aug 15; 310(2):452-8. PubMed ID: 15082754
    [Abstract] [Full Text] [Related]

  • 38. Oxidative stress disrupts nitric oxide synthase activation in liver endothelial cells.
    Karaa A, Kamoun WS, Clemens MG.
    Free Radic Biol Med; 2005 Nov 15; 39(10):1320-31. PubMed ID: 16257641
    [Abstract] [Full Text] [Related]

  • 39. Antiangiogenic effect of alpha-anordrin in vitro and in vivo.
    Ma ZC, Lou LG, Zhang Z, Xu B.
    Acta Pharmacol Sin; 2000 Oct 15; 21(10):939-44. PubMed ID: 11501049
    [Abstract] [Full Text] [Related]

  • 40. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
    Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR.
    Cancer Res; 2000 Dec 15; 60(24):6958-63. PubMed ID: 11156396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.